Get the Stockscreener App
12.63
2.85%
-0.37
After Hours:
12.70
0.07
+0.55%
Cidara Therapeutics Inc Stock (CDTX) Forecast
The Cidara Therapeutics Inc (CDTX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.9085, representing a -92.81% decrease from the current price of $12.63. The highest analyst price target is $1.2526, and the lowest is $0.5644.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CDTX Price Target
Average 1.5208
(-87.96% Downside)
Is Cidara Therapeutics Inc (CDTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 93.46 | Sell |
| STOCH(9,6) | 45.61 | Neutral |
| STOCHRSI(14) | 95.43 | Sell |
| MACD(12,26) | 2.2037 | Buy |
| ADX(14) | 38.81 | Buy |
| William %R | -16.11 | Sell |
| CCI(14) | 155.89 | Buy |
Buy: 3
Sell: 3
Neutral: 1
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.2626
Buy
|
6.1106
Buy
|
| MA20 |
2.6237
Buy
|
3.8492
Buy
|
| MA50 |
1.4815
Buy
|
2.1177
Buy
|
| MA100 |
1.1063
Buy
|
1.4736
Buy
|
| MA200 |
1.0046
Buy
|
1.2113
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, CDTX could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 3 signaling Sell signals and 1 Neutral signals. This might be a good time to open fresh positions on CDTX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 93.46 indicates that CDTX is overbought. This suggests that CDTX price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 45.61 indicates that CDTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 95.43 indicates that CDTX is oversold. This suggests that CDTX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 38.81 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 155.89 indicates that CDTX is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term CDTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cidara Therapeutics Inc financial reports and earnings history, Cidara Therapeutics Inc (CDTX) stock could reach $0.7212 by 2030, $0.444 by 2040 and $3.9453 by 2050. See the projected annual prices until 2050 of the Cidara Therapeutics Inc stock below:
- Cidara Therapeutics Inc (CDTX) is expected to reach an average price of $0.3345 in 2035, with a high prediction of $0.2305 and a low estimate of $0.2169. This indicates an $-97.35% rise from the last recorded price of $12.63.
- Cidara Therapeutics Inc (CDTX) stock is projected to chart a bullish course in 2040, with an average price target of $0.9068, representing an $-92.82% surge from its current level. The forecast ranges from a conservative $0.6013 to a sky-high $0.444.
- Our analysts predict Cidara Therapeutics Inc (CDTX) to jump -79.33% by 2045, soaring from $2.6263 to an average price of $2.6106, potentially reaching $2.598. While $2.6263 is the low estimate, the potential upside is significant.
- Cidara Therapeutics Inc (CDTX) stock is expected to climb by 2050, reaching an average of $3.9428, a $-68.78% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.9453 and $3.9402, respectively, highlighting the market's uncertainty.
Cidara Therapeutics Inc Stock (CDTX) Year by Year Forecast
Cidara Therapeutics Inc Stock (CDTX) Price Forecast for 2024
Our forecast for CDTX stock price in 2024 now indicates an average price target of $0.8289 with a high forecast of $1.6397 and a low forecast of $0.0181. The average prediction reflects an decrease of -93.44% from the last recorded price of $12.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $0.8644 | $0.5644 | $1.2526 | -93.16% |
| June, 2024 | $0.0701 | $0.0201 | $0.8884 | -99.44% |
| July, 2024 | $0.0898 | $0.0181 | $0.3541 | -99.29% |
| August, 2024 | $0.1245 | $0.0513 | $0.6455 | -99.01% |
| September, 2024 | $0.2152 | $0.1947 | $0.3352 | -98.30% |
| October, 2024 | $0.4609 | $0.3109 | $1.5591 | -96.35% |
| November, 2024 | $0.4267 | $0.2427 | $0.5188 | -96.62% |
| December, 2024 | $0.9363 | $0.3306 | $1.0744 | -92.59% |
Cidara Therapeutics Inc Stock (CDTX) Price Forecast for 2025
Cidara Therapeutics Inc Stock (CDTX) is expected to reach an average price of $1.6065 in 2025, with a high prediction of $3.124 and a low estimate of $0.0889. This indicates an -87.28% fall from the last recorded price of $12.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.1321 | $0.7303 | $1.3721 | -91.04% |
| February, 2025 | $1.9978 | $0.926 | $2.5478 | -84.18% |
| March, 2025 | $1.5875 | $1.4475 | $3.0235 | -87.43% |
| April, 2025 | $1.5032 | $1.2732 | $2.0432 | -88.10% |
| May, 2025 | $1.0589 | $0.0889 | $1.387 | -91.62% |
| June, 2025 | $1.4686 | $0.9028 | $1.5836 | -88.37% |
| July, 2025 | $2.2343 | $1.3125 | $2.2793 | -82.31% |
| August, 2025 | $2.64 | $2.0061 | $2.84 | -79.10% |
| September, 2025 | $2.5197 | $1.9997 | $3.124 | -80.05% |
| October, 2025 | $2.5054 | $2.1715 | $3.0454 | -80.16% |
| November, 2025 | $1.8012 | $1.7012 | $2.6794 | -85.74% |
| December, 2025 | $1.5508 | $1.5408 | $2.1255 | -87.72% |
Cidara Therapeutics Inc Stock (CDTX) Price Forecast for 2026
The predicted value for Cidara Therapeutics Inc (CDTX) in 2026 is set at an average of $1.1988. Estimates vary from a peak of $2.0238 to a trough of $0.3739, indicating an -90.51% surge from the present price of $12.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.3666 | $1.3366 | $2.0238 | -89.18% |
| February, 2026 | $1.1023 | $0.5844 | $1.4928 | -91.27% |
| March, 2026 | $0.852 | $0.748 | $1.2202 | -93.25% |
| April, 2026 | $1.3177 | $0.7159 | $1.3977 | -89.57% |
| May, 2026 | $1.5834 | $1.1116 | $1.9734 | -87.46% |
| June, 2026 | $1.1331 | $0.9313 | $1.6753 | -91.03% |
| July, 2026 | $0.9988 | $0.9388 | $1.9349 | -92.09% |
| August, 2026 | $0.9085 | $0.6345 | $1.2367 | -92.81% |
| September, 2026 | $0.9242 | $0.8174 | $1.1303 | -92.68% |
| October, 2026 | $0.8099 | $0.6399 | $1.0021 | -93.59% |
| November, 2026 | $0.6096 | $0.3739 | $0.8539 | -95.17% |
| December, 2026 | $1.0953 | $0.5635 | $1.2752 | -91.33% |
Cidara Therapeutics Inc Stock (CDTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cidara Therapeutics Inc (CDTX) is $0.6975, with a high forecast of $1.3511 and a low forecast of $0.044. This indicates an -94.48% decrease from the last price of $12.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.1919 | $0.9532 | $1.3511 | -90.56% |
| February, 2027 | $0.5268 | $0.5268 | $1.215 | -95.83% |
| March, 2027 | $0.4665 | $0.3065 | $0.7525 | -96.31% |
| April, 2027 | $0.4622 | $0.1122 | $0.7182 | -96.34% |
| May, 2027 | $0.1412 | $0.044 | $0.4961 | -98.88% |
| June, 2027 | $0.1474 | $0.1001 | $0.0884 | -98.83% |
| July, 2027 | $0.2516 | $0.1879 | $0.2206 | -98.01% |
| August, 2027 | $0.037 | $0.0694 | $0.1728 | -99.71% |
| September, 2027 | $0.2044 | $0.11 | $0.0882 | -98.38% |
| October, 2027 | $0.427 | $0.2074 | $0.3856 | -96.62% |
| November, 2027 | $0.3459 | $0.3677 | $0.4078 | -97.26% |
| December, 2027 | $0.1437 | $0.1802 | $0.3705 | -98.86% |
Cidara Therapeutics Inc Stock (CDTX) Price Forecast for 2028
In 2028, Cidara Therapeutics Inc (CDTX) is projected to reach an average price of $0.7101, with a high projection of $1.4111 and a low estimate of $0.00906. This indicates an -94.38% fall from the last price of $12.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.1006 | $0.1546 | $0.0959 | -99.20% |
| February, 2028 | $0.1187 | $0.1466 | $0.0849 | -99.06% |
| March, 2028 | $0.1628 | $0.153 | $0.123 | -98.71% |
| April, 2028 | $0.1683 | $0.1864 | $0.1687 | -98.67% |
| May, 2028 | $0.1236 | $0.1537 | $0.1874 | -99.02% |
| June, 2028 | $0.0683 | $0.1747 | $0.1594 | -99.46% |
| July, 2028 | $0.4817 | $0.00906 | $0.8678 | -96.19% |
| August, 2028 | $0.9075 | $0.4357 | $1.0835 | -92.81% |
| September, 2028 | $0.8632 | $0.6453 | $1.2893 | -93.17% |
| October, 2028 | $0.4029 | $0.2463 | $1.4111 | -96.81% |
| November, 2028 | $0.5086 | $0.3059 | $0.6286 | -95.97% |
| December, 2028 | $0.6643 | $0.4325 | $0.8265 | -94.74% |
Cidara Therapeutics Inc Stock (CDTX) Price Forecast for 2029
The 2029 price forecast for Cidara Therapeutics Inc Stock (CDTX) is $0.4239 on average, with a high prediction of $0.7942 and a low estimate of $0.0535. This represents an -96.64% decrease from the previous price of $12.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.484 | $0.4101 | $0.7383 | -96.17% |
| February, 2029 | $0.385 | $0.2819 | $0.5619 | -96.95% |
| March, 2029 | $0.1804 | $0.1503 | $0.4736 | -98.57% |
| April, 2029 | $0.4451 | $0.1594 | $0.6451 | -96.48% |
| May, 2029 | $0.2968 | $0.2708 | $0.463 | -97.65% |
| June, 2029 | $0.2266 | $0.1742 | $0.3696 | -98.21% |
| July, 2029 | $0.2161 | $0.0535 | $0.3005 | -98.29% |
| August, 2029 | $0.9863 | $0.1814 | $0.7942 | -92.19% |
| September, 2029 | $0.4049 | $0.4949 | $0.2649 | -96.79% |
| October, 2029 | $0.5155 | $0.517 | $0.5155 | -95.92% |
| November, 2029 | $0.7341 | $0.3498 | $0.3761 | -94.19% |
| December, 2029 | $0.7948 | $0.5426 | $0.5762 | -93.71% |
Cidara Therapeutics Inc Stock (CDTX) Price Forecast for 2030
Cidara Therapeutics Inc Stock (CDTX) is expected to reach an average price of $0.8601 in 2030, with a high forecast of $1.6853 and a low forecast of $0.0349. This signifies an -93.19% decrease from the last price of $12.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.0833 | $0.939 | $0.7212 | -91.42% |
| February, 2030 | $1.5118 | $1.2354 | $1.2118 | -88.03% |
| March, 2030 | $1.4604 | $1.5234 | $1.474 | -88.44% |
| April, 2030 | $1.711 | $1.4425 | $1.6479 | -86.45% |
| May, 2030 | $1.2996 | $1.7095 | $1.6853 | -89.71% |
| June, 2030 | $1.0381 | $0.9817 | $1.0052 | -91.78% |
| July, 2030 | $1.0638 | $1.0503 | $1.0145 | -91.58% |
| August, 2030 | $0.5273 | $0.7331 | $0.6509 | -95.82% |
| September, 2030 | $0.478 | $0.4459 | $0.4795 | -96.22% |
| October, 2030 | $0.6634 | $0.1477 | $1.1156 | -94.75% |
| November, 2030 | $0.1749 | $0.0349 | $1.607 | -98.62% |
| December, 2030 | $0.5158 | $0.0428 | $0.6464 | -95.92% |
1.53%
3.38%
Cap:
|
Volume (24h):